Literature DB >> 8648934

Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission.

L Stuyver1, H Claeys, A Wyseur, W Van Arnhem, H De Beenhouwer, S Uytendaele, J Beckers, D Matthijs, G Leroux-Roels, G Maertens, M De Paepe.   

Abstract

Between February 1991 and January 1992, elevated alanine aminotransferase (ALT) levels were observed in several hemodialysis patients in a dialysis center in Dendermonde, Belgium. By the end of 1992, 25 out of 68 patients had seroconverted for HCV antibodies. The HCV strains from 23 of these seroconverters were genotyped and classified as genotype 1b. Sequence analysis of the HCV Core region was carried out in 12 patients, 9 of whom were infected with a strain bearing a unique sequence motif as compared with the currently known HCV 1b strains. A new 5' UR/Core line probe assay was designed to screen for such variations. Twenty patients tested positively for this special sequence motif, while the other 3 showed the regular subtype 1b sequence. Phylogenetic analysis of the Core sequences further revealed that the latter three were neither related to the main special strain of the infection, nor to each other. These three strains could be traced to two patients already infected at the time of residence in other dialysis units and to one patient who already showed ALT elevations in 1989. Epidemiological studies revealed no traceable source for this outbreak. In conclusion, molecular analysis demonstrates nosocomial transmissions by a peculiar genotype 1b strain in a dialysis center. Three other genotype 1b strains were also present in the unit, but were not responsible for the outbreak.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648934     DOI: 10.1038/ki.1996.122

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Follow-up study of hepatitis C virus infection in uremic patients on maintenance hemodialysis for 30 months.

Authors:  Nian-Song Wang; Lu-Tan Liao; Yan-Juan Zhu; Wei Pan; Fang Fang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Hepatitis C infection in risk groups.

Authors:  Sead Ahmetagić; Kasim Muminhodzić; Elmir Cickusić; Vildana Stojić; Jasminka Petrović; Nijaz Tihić
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

Review 3.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

4.  Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis units.

Authors:  M Mizuno; T Higuchi; K Kanmatsuse; M Esumi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 5.  Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.

Authors:  Chukwuma Mbaeyi; Nicola D Thompson
Journal:  Semin Dial       Date:  2013-05-31       Impact factor: 3.455

6.  Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit.

Authors:  Philippe Halfon; Christa Roubicek; Victoria Gerolami; Yves Quentin; Hacene Khiri; Gérad Pepe; Yvon Berland
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized.

Authors:  Sanjay Kumar Agarwal; Suresh Chand Dash; Sanjay Gupta; Ravinder Mohan Pandey
Journal:  Nephron Clin Pract       Date:  2009-01-16

8.  Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital.

Authors:  S Jasuja; A K Gupta; R Choudhry; V Kher; D K Aggarwal; A Mishra; M Agarwal; A Sarin; M K Mishra; V Raina
Journal:  Indian J Nephrol       Date:  2009-04

9.  High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence.

Authors:  F H Pujol; J G Ponce; M G Lema; F Capriles; M Devesa; F Sirit; M Salazar; G Vásquez; F Monsalve; L Blitz-Dorfman
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

10.  A cost-identification analysis of screening and surveillance of hepatitis C infection in a prospective cohort of dialysis patients.

Authors:  Ma Somsouk; Deston E Langfield; John M Inadomi; Hal F Yee
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.